R. Janet Whitmore - 24 Dec 2025 Form 4 Insider Report for SOLESENCE, INC. (SLSN)

Reporting relationship: Director
Issuer ticker: SLSN
Reported as of: 24 Dec 2025
Net transaction value: +$4,787
SEC form: 4
Accepted by SEC: 30 Dec 2025, 09:29:40 UTC
Prior SEC filing: 11 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Laura Riffner, Under UPA for R. Janet Whitmore

Key filing fact

R. Janet Whitmore filed Form 4 for SOLESENCE, INC. (SLSN) on 30 Dec 2025.

Key facts

This page summarizes R. Janet Whitmore's Form 4 filing for SOLESENCE, INC. (SLSN).
2 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 30 Dec 2025, 09:29.

Change

Previous filing in this sequence was filed on 11 Dec 2025.
Current net transaction value: +$4,787.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001173970 Primary reporting owner

WHITMORE R JANET

Relationship: Director
Address: 1319 MARQUETTE DRIVE, ROMEOVILLE
Signature: /s/ Laura Riffner, Under UPA for R. Janet Whitmore
Signature date: 30 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLSN transaction

Common Stock

Purchase

Transaction value: $2,865
Shares: +1,500
Change %: +0.07%
Price: $1.91
Shares after: 2,085,698
Date: 24 Dec 2025
Ownership: Direct

SLSN transaction

Common Stock

Purchase

Transaction value: $1,922
Shares: +1,000
Change %: +0.05%
Price: $1.92
Shares after: 2,086,698
Date: 24 Dec 2025
Ownership: Direct

SLSN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,084,198
Date: 24 Dec 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLSN holding Derivative

Deferred Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 20,030
Date: 24 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,030
Exercise price
Footnotes: F1, F2, F3

SLSN holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,000
Date: 24 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,000
Exercise price: $1.85
Footnotes: F4

SLSN holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 20,000
Date: 24 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $4.17
Footnotes: F5

SLSN holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,334
Date: 24 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,334
Exercise price: $1.16
Footnotes: F5

SLSN holding Derivative

Common Stock (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,600
Date: 24 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,600
Exercise price: $0.6100
Footnotes: F5

SLSN holding Derivative

Common Stock (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,000
Date: 24 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,000
Exercise price: $2.44
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each share of deferred common stock represents the right to receive one share of common stock.

Footnote F2

The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.

Footnote F3

Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensaion Plan.

Footnote F4

The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. These 2000 shares were issued with an exercise price of $1.85.

Footnote F5

Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .